History
| In 1999, recognising the paucity of effective drugs in the world’s poorer regions where they worked, Médecins Sans Frontières (MSF) brought together a team of international experts to study the crisis in drug research and development (R&D) for neglected diseases. This Drugs for Neglected Diseases working group analysed the causes of the crisis, and in developing innovative strategies to ensure the development of new and affordable medicines for neglected diseases, recommended the creation of a new initiative, DNDi. | ||
 DNDi Funding Ceremony, July 3, 2003 | In 2003, 7 organisations from around the world joined forces to establish DNDi: 5 public sector institutions – the Oswaldo Cruz Foundation from Brazil, the Indian Council for Medical Research, the Kenya Medical Research Institute, the Ministry of Health of Malaysia and France’s Pasteur Institute; one humanitarian organisation, Médecins sans Frontières (MSF); and one international research organisation, the UNDP/World Bank/WHO’s Special Programme for Research and Training in Tropical Diseases (TDR), which acts as a permanent observer to the initiative. | |
| The DNDi became a legal entity in July 2003. | ||
Except where otherwise noted, content on this site is licensed under
a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Switzerland License